Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares
August 22, 2025 12:00 ET | Source: Invivyd WALTHAM, Mass., Aug. 22,…
Invivyd Announces Continued Neutralizing Activity of PEMGARDA (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (Stratus)
August 18, 2025 16:32 ET | Source: Invivyd New in vitro neutralization…
